Methods of determining whether a patient suffering froma

Pheochromocytomas produce and store catecholamines. The release of excessive amounts of catecholamine can lead to life-threatening […]

Methods of assessing the risk of developing progressivemultifocal

Natalizumab a monoclonal antibody is associated with the risk of progressive multifocal leukoencephalopathy (PML), an infection caused by the John […]

Methods of determining whether patients suffering from acute myeloid

Deciphering the impact of metabolic intervention on response to anticancer therapy represents a path toward improved clinical responses. Here, the […]

New biomarkers for diagnosis and treatment monitoring for anemia

The invention relates to the domain of anemia, iron overload and myeloid malignancy. The inventors identify a variant transcript of ERFE specific of […]

Biomarker and methods for predicting intracranial aneurysm

The present invention relates to a method for predicting the risk of having or developing Intracranial aneurysms (IA) in a subject, by identifying at […]

Ssbp1 as a new target, and biomarker for predicting risk of ocular

Inventors report heterozygous mutations in mitochondrial single-stranded DNA-binding protein SSBP1 in multiple unrelated families with non-syndromic […]